Masimo Corp Files Definitive Proxy Statement
Ticker: MASI · Form: DEFA14A · Filed: May 13, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | DEFA14A |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, sec
TL;DR
Masimo Corp just dropped its definitive proxy statement, shareholders pay attention.
AI Summary
Masimo Corporation filed a DEFA14A, indicating it is providing soliciting material under Rule 240.14a-12. This filing is not a preliminary proxy statement or definitive additional materials, but rather definitive proxy statement material. The company is based in Irvine, CA, and operates in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing is a standard regulatory disclosure for Masimo Corporation, providing shareholders with important information related to their proxy voting rights and company matters.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not inherently present new financial or operational risks.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- Irvine, CA (location) — Company Address
- 240.14a-12 (regulation) — Rule cited for soliciting material
FAQ
What type of filing is this DEFA14A for Masimo Corporation?
This DEFA14A filing is classified as Soliciting Material Pursuant to §240.14a-12 and is a Definitive Proxy Statement.
What is Masimo Corporation's primary industry?
Masimo Corporation is in the Electromedical & Electrotherapeutic Apparatus industry, SIC code 3845.
Where is Masimo Corporation headquartered?
Masimo Corporation's business and mailing address is 52 Discovery, Irvine, CA 92618.
What is the filing date for this document?
The filing date for this DEFA14A is May 13, 2024.
Is a filing fee required for this submission?
No fee is required for this filing, as indicated by the checked box for 'No fee required'.
Filing Stats: 1,512 words · 6 min read · ~5 pages · Grade level 13.9 · Accepted 2024-05-13 08:30:03
Filing Documents
- ea0205882-defa14a_masimo.htm (DEFA14A) — 23KB
- image_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-041927.txt ( ) — 28KB
Forward-Looking Statements
Forward-Looking Statements This communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo Corporation (“Masimo” or the “Company”), the settlement offer made by Masimo to Quentin Koffey of Politan Capital Management LP (“Politan”), Masimo’s strategic plans and the evaluation of the proposed separation of its Consumer Business and the potential benefits of such separation. These forward-looking are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding a potential separation of Masimo’s Consumer Business, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk Factors” section of Masimo’s most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at www.sec.gov . Although Masimo believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not know